Ren Yan-Gang, Zhou Xiao-Ming, Cui Zhi-Gang, Hou Gang
1 Publishing House of Chinese Journal of Practical Medicine, China Medical University, Shenyang 110001, China ; 2 Department of Respiratory Disease, The Shengjing Hospital of China Medical University, Shenyang 110004, China ; 3 School of Nusring, China Medical University, Shenyang 110122, China ; 4 Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang 110001, China.
J Thorac Dis. 2016 Jun;8(6):1297-305. doi: 10.21037/jtd.2016.05.02.
BACKGROUND: MicroRNAs (miRNAs) may play an important role in organ development, cell differentiation, apoptosis, proliferation, cell growth regulation and act as tumor suppressor genes or proto-oncogenes. Single nucleotide polymorphisms (SNPs) in miRNAs are considered to be genetic factors to influence the susceptibility to lung cancer (LC). Rs2910164 in miR-146a and rs11614913 in miR-196a2 are shown to be associated with increased/decreased LC risk. The aim of this meta-analysis was to systematically summarize the possible association. METHODS: The relevant articles were retrieved from several important databases. Studies were selected using specific inclusion and exclusion criteria. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the strength of association between miRNA polymorphism and susceptibility to LC. All analyses were performed using the Stata software. RESULTS: Seven studies were included in this meta-analysis. There were 3,225 cases and 3,268 controls for SNP rs2910164 and 2,794 cases and 2,840 controls for SNP rs11614913. The significant associations between SNP rs2910164 and LC risk were observed (CC vs. GG: OR =1.30, 95% CI: 1.13-1.50; CC + GC vs. GG: OR =1.15, 95% CI: 1.02-1.29; CC vs. GC + GG: OR =1.27, 95% CI: 1.13-1.42; C vs. G: OR =1.15, 95% CI: 1.08-1.24). SNP rs11614913 was found to be associated with LC risk in most genetic models (TC vs. TT: OR =1.16, 95% CI: 1.02-1.32; CC vs. TT: OR =1.24, 95% CI: 1.06-1.44; CC + TC vs. TT: OR =1.19, 95% CI: 1.06-1.34; C vs. T: OR =1.11, 95% CI: 1.03-1.20). In the subgroup analysis by ethnicity, genotyping method and control characteristics, significantly affected LC risks were also suggested. CONCLUSIONS: The rs2910164 in miR-146a and the rs11614913 in miR-196a2 are likely to be associated with LC risks.
背景:微小RNA(miRNA)可能在器官发育、细胞分化、凋亡、增殖、细胞生长调节中发挥重要作用,并作为肿瘤抑制基因或原癌基因。miRNA中的单核苷酸多态性(SNP)被认为是影响肺癌(LC)易感性的遗传因素。miR-146a中的rs2910164和miR-196a2中的rs11614913已被证明与LC风险的增加/降低有关。本荟萃分析的目的是系统总结可能的关联。 方法:从几个重要数据库中检索相关文章。使用特定的纳入和排除标准选择研究。计算比值比(OR)和95%置信区间(CI)以评估miRNA多态性与LC易感性之间关联的强度。所有分析均使用Stata软件进行。 结果:本荟萃分析纳入了7项研究。SNP rs2910164有3225例病例和3268例对照,SNP rs11614913有2794例病例和2840例对照。观察到SNP rs2910164与LC风险之间存在显著关联(CC与GG:OR = 1.30,95% CI:1.13 - 1.50;CC + GC与GG:OR = 1.15,95% CI:1.02 - 1.29;CC与GC + GG:OR = 1.27,95% CI:1.13 - 1.42;C与G:OR = 1.15,95% CI:1.08 - 1.24)。发现SNP rs11614913在大多数遗传模型中与LC风险相关(TC与TT:OR = 1.16,95% CI:1.02 - 1.32;CC与TT:OR = 1.24,95% CI:1.06 - 1.44;CC + TC与TT:OR = 1.19,95% CI:1.06 - 1.34;C与T:OR = 1.11,95% CI:1.03 - 1.20)。在按种族、基因分型方法和对照特征进行的亚组分析中,也提示了对LC风险有显著影响。 结论:miR-146a中的rs2910164和miR-196a2中的rs11614913可能与LC风险相关。
Onco Targets Ther. 2018-4-30
Clin Res Hepatol Gastroenterol. 2017-12
Genes (Basel). 2023-6-29
Technol Cancer Res Treat. 2022
Diagnostics (Basel). 2021-2-10
Medicine (Baltimore). 2019-2
Nat Rev Clin Oncol. 2016-9
CA Cancer J Clin. 2015-2-4